Cefoxitin treatment of MRSA leads to a shift in the IL-12/IL-23 production pattern in dendritic cells by a mechanism involving changes in the MAPK signaling

Publication date: June 2021Source: Molecular Immunology, Volume 134Author(s): Helene M.S. Eld, Emilie M. Nielsen, Peter R. Johnsen, Mauro Marengo, Ida W. Kamper, Lise Frederiksen, Francesco Bonomi, Dorte Frees, Stefania Iametti, Hanne Frøkiær
Source: Molecular Immunology - Category: Allergy & Immunology Source Type: research